APUS
Apimeds Pharmaceuticals US, Inc.
NYSE MKT: APUS · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$1.88
+0.00% today
Updated 2026-04-29
Market cap
$2.36M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.41
Dividend yield
—
52W range
$1 – $4
Volume
0.1M
Apimeds Pharmaceuticals US, Inc. (APUS) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
0 of 3
Last 3 quarters
Avg EPS surprise
—
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
—
Most recent quarter
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+4.5%
Last 1 reports
Positive reaction rate
100%
1 of 1 quarters
Largest single-day move
+4.5%
2025-11-12
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2025-11-12 | $-0.14 | — | $2.67 | $2.79 | +4.5% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-09-30 | — | $-0.14 | — | — | — |
| 2025-06-30 | — | $-0.26 | — | — | — |
| 2025-03-31 | $0.00 | $-0.04 | — | — | — |
Frequently asked questions
Has Apimeds Pharmaceuticals US, Inc. beaten earnings estimates?
Apimeds Pharmaceuticals US, Inc. has beaten Wall Street EPS estimates in 0 of its last 3 quarterly reports.
How does APUS stock react to earnings?
APUS stock has moved an average of +4.5% in the trading day following earnings over its last 1 reports, with positive reactions in 100% of those quarters.